ColiseoHead-to-Head Startup Ranking & Discovery
T
Our lead candidate is a multifaceted attack antibody for ovarian cancer. Our approach enables targeting primary cancer cells directly, alongside enabling the immune system's natural anti-cancer function, all with one therapeutic antibody.
Founded
2018
Headquarters
San Francisco, CA, USA
Team size
1–10
Stage
Early-stage
📊 Coliseo ratings
🏆 Overall 1472 Elo
Total matchups0
⚔️ Vote on today's matchups →Ratings are live Elo scores from head-to-head crowd votes — opinion, not fact or financial advice. How it works →